Literature DB >> 20136419

Broccoli regulates protein alterations and cataractogenesis in selenite models.

M Vibin1, S G Siva Priya, B N Rooban, V Sasikala, V Sahasranamam, Annie Abraham.   

Abstract

PURPOSE: To study the efficacy of Brassica oleracea var. italica (Broccoli) in the prevention of selenite induced biochemical changes and the incidence of cataractogenesis in vivo.
METHODS: Eight day old Sprague-Dawley rat pups were divided into four groups: I-Control; II-Sodium selenite (4 mg/kg body weight) administered; III-Sodium selenite + quercetin; and IV-Sodium selenite + flavonoid fraction of broccoli (FFB). Treatment groups III and IV received quercetin and FFB intraperitoneally from 8th to 15th day at a concentration (2.0 mg/kg body weight). The development of cataract was assessed and graded by slit-lamp examination. Some relevant biochemical parameters-such as activities of superoxide dismutase (SOD), catalase, Ca(2+)ATPase, calpains, concentration of reduced glutathione (GSH), levels of calcium, lipid peroxidation product-thiobarbituric acid reacting substances (TBARS) and SDS-PAGE analysis of lens water soluble proteins (WSF) were analyzed.
RESULTS: FFB modulates selenite-induced biochemical changes in albino rats. Lenses of Group I rats were clear but in Group II, all lenses developed dense opacification (grade 5 and 6), whereas mild opacifications were observed in Group III and Group IV (grade 2). Group III and Group IV lenses exhibited significantly higher values of antioxidant enzymes, Ca(2+)ATPase, and GSH, whereas lower values were obtained for TBARS, calcium, and calpains compared to Group II. Lens protein profile of water soluble proteins showed normal levels of Group III and Group IV compared to Group II lenses.
CONCLUSION: FFB prevents selenite-induced cataractogenesis in albino rat pups, possibly by maintaining antioxidant status and ionic balance through Ca(2+) ATPase pump, inhibition of lipid peroxidation, calpain activation, and protein insolubilization, which have been reported in this article for the first time.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20136419     DOI: 10.3109/02713680903428991

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  7 in total

Review 1.  Protein misfolding and aggregation in cataract disease and prospects for prevention.

Authors:  Kate L Moreau; Jonathan A King
Journal:  Trends Mol Med       Date:  2012-04-19       Impact factor: 11.951

2.  Amelioration of selenite toxicity and cataractogenesis in cultured rat lenses by Vitex negundo.

Authors:  B N Rooban; V Sasikala; V Sahasranamam; Annie Abraham
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-15       Impact factor: 3.117

3.  Deciphering the potential efficacy of acetyl-L-carnitine (ALCAR) in maintaining connexin-mediated lenticular homeostasis.

Authors:  Arumugam Ramachandran Muralidharan; George Leema; Thangaraj Annadurai; Thirugnanasambandhar Sivasubramanian Anitha; Philip A Thomas; Pitchairaj Geraldine
Journal:  Mol Vis       Date:  2012-07-25       Impact factor: 2.367

4.  Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract.

Authors:  Milan Stefek
Journal:  Interdiscip Toxicol       Date:  2011-06

5.  Regulatory effect of chrysin on expression of lenticular calcium transporters, calpains, and apoptotic-cascade components in selenite-induced cataract.

Authors:  Mahalingam Sundararajan; Philip A Thomas; P Archana Teresa; Muniyandi Anbukkarasi; Pitchairaj Geraldine
Journal:  Mol Vis       Date:  2016-04-30       Impact factor: 2.367

6.  Postponement of the opacification of lentoid bodies derived from human induced pluripotent stem cells after lanosterol treatment-the first use of the lens aging model in vitro in cataract drug screening.

Authors:  Lifang Zhang; Zhenwei Qin; Danni Lyu; Bing Lu; Zhijian Chen; Qiuli Fu; Ke Yao
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

Review 7.  Current Trends in the Pharmacotherapy of Cataracts.

Authors:  Segewkal H Heruye; Leonce N Maffofou Nkenyi; Neetu U Singh; Dariush Yalzadeh; Kalu K Ngele; Ya-Fatou Njie-Mbye; Sunny E Ohia; Catherine A Opere
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.